Drugs Made In America Acquisition Corp. (DMAA)
Drugs Made In America Acquisition Corp.
$10.70+0.00%Financial Services
StockGlow Score
Bullish
BearishBullish
1 year ago+4.2%
The outlook
Drugs Made In America Acquisition Corp. currently reads as bullish based on above its 50- & 200-day averages, 96% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range96% of the way from its 52-week low to high
Market cap
$259.8M
52-wk high
$10.72
52-wk low
$10.22
50-day avg
$10.64
200-day avg
$10.48
Trailing P/E
53.5